AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$0.13 USD
-0.01 (-9.93%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $0.13 0.00 (2.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/4/25 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.72 |
Next Year | -0.69 |
EPS (TTM) | -1.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.19 | 0.72 | -0.69 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.18 | -0.19 | 0.72 | -0.69 |
High Estimate | -0.18 | -0.19 | 0.72 | -0.69 |
Low Estimate | -0.18 | -0.19 | 0.72 | -0.69 |
Year ago EPS | -0.71 | -0.28 | NA | 0.72 |
Year over Year Growth Est. | 74.65% | 32.14% | NA | -195.83% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.19 | 0.72 | -0.69 |
7 Days Ago | -0.18 | -0.19 | 0.72 | -0.69 |
30 Days Ago | -0.18 | -0.19 | 0.72 | -0.69 |
60 Days Ago | -0.18 | -0.19 | 0.72 | -0.69 |
90 Days Ago | -0.18 | -0.19 | 0.72 | -0.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.19 | 0.72 | -0.69 |
Zacks Consensus Estimate | -0.18 | -0.19 | 0.72 | -0.69 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.16 | -0.28 | -0.71 | NA |
Estimate | -0.16 | -0.19 | -0.31 | -0.40 | NA |
Difference | 0.00 | 0.03 | 0.03 | -0.31 | -0.06 |
Surprise | 0.00% | 15.79% | 9.68% | -77.50% | -13.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more